Abstract
Objective
Neprilysin (neutral endopeptidase, 3:4:24:11, CD10) (NEP) is a Zn metallopeptidase linked to controlling inflammation through the degradation of neuropeptides involved in neurogenic inflammation of chronic rheumatic diseases. The aim of our study was to evaluate circulating activity and cellular expression of NEP in the plasma of 58 children with juvenile idiopathic arthritis (JIA) and 52 controls. In 20 subjects requiring local steroid injection, NEP was measured in synovial fluid.
Methods
Plasma and synovial NEP were evaluated using a fluorimetric technique. Neprilysin, expressed as the antigen CD10, was determined on circulating and synovial fluid cells as mean fluorescence intensity (MFI) and as percentage of positive cells by two-color immunofluorescence.
Results
Circulating NEP levels were lower in JIA patients than in controls (42.0±16.6 vs 76.5±24 pmol/ml per min, P<0.001), while synovial fluid NEP values were higher than circulating levels (241.4±86.2 vs 40±15.3 pmol/ml per min, P<0.001). In monocytes, the percentage of CD10-positive circulating cells and the MFI in JIA were lower than in controls (11.6±5.2% vs 41.4±13%, P<0.001 and 18.1±7.5 vs 31.2±5.4, P<0.05, respectively). On synovial monocytes, the percentage of CD10-positive cells and the MFI were higher than on circulating monocytes (35.2±14.6% vs 9.1±2.4%, P<0.001 and 66.4±5.4 vs 22.8±14.7, P<0.001, respectively).
Conclusions
The downregulation of CD10 expression in monocytes and the reduction in NEP activity may be linked to the enzyme’s role in the control of peptides involved in the inflammation. The increased levels of NEP, MFI, and CD10-positive monocytes in synovial fluid, even though in plasma, might reflect a reactive effort to control synovial proliferation.
Similar content being viewed by others
References
Cassidy JT (2001) Juvenile rheumatoid arthritis. In: Cassidy JT, Petty RE (eds) Textbook of pediatric rheumatology. Fourth edn. Churchill Livingston, New York, pp 113–219
Turner AJ, Barnes K, Murphy LJ, Medairos MS (1996) Endopeptidase (neprilysin) and relatives: twenty years on. Adv Exp Med Biol 389:141–148
Mapp I, Walsh DA, Kidd BL, Cruwys SC, Polak JM, Blake DR (1992) Localization of the enzyme neutral endopeptidase to the human synovium. J Rheumatol 19:1838–1844
Iwamoto I, Kimura A, Ochiai K, Tomioka H, Yoshida S (1991) Distribution of neutral endopeptidase in human blood leukocytes. J Leuk Biol 49:116–125
Cossman J, Neckers LM, Leonard WJ, Greene WC (1983) Polymorphonuclear neutrophils express the common acute lymphoblastic leukemia antigen. J Exp Med 157:1064–1069
Matucci-Cerinic M, Partsch G (1992) The contribution of the peripheral nervous system and the neuropeptide network to the development of synovial inflammation. Clin Exp Rheumatol 10:211–215
Koehne P, Schaper C, Graf K, Kunkel G (1998) Neutral endopeptidase 24.11: its physiologic and possibly pathophysiologic role in inflammation with special effect on respiratory inflammation. Allergy 53:1023–1042
Sreedharan SP, Goetzl EJ, Malfroy B (1990) Elevated synovial tissue concentration of the common acute lymphoblastic leukemia antigen (CALLA)-associated neutral endopeptidase (3.4.24.1) in human chronic arthritis. Immunology 71:142–144
Matucci-Cerinic M, Iannone F, Carossino A, Pignone A, Leoncini G, Generini S, Lapadula G, Cagnoni M (1999) Discrepant expression of neprilysin on fibroblasts in diffuse systemic sclerosis. J Rheumatol 26:347–351
Matucci-Cerinic M, Lombardi A, Leoncini G, Pignone A, Sacerdoti L, Spillantini MG, Partsch G (1993) Neutral endopeptidase (3,4,24,11) in plasma and synovial fluid of patients with rheumatoid arthritis. A marker of disease activity or a regulator of pain and inflammation? Rheumatol Int 13:1–4
Falcini F, Matucci Cerinic M, Lombardi L, Generini S, Pignone A, Tirassa P, Ermini M, Lepore L, Partsch G, Aloe L (1996) Increased circulating nerve growth factor is directly correlated with disease activity in juvenile chronic arthritis. Ann Rheum Dis 55:745–748
Falcini F, Azzari C, Gelli AMG, Luchetti M, Gabrielli A, Calzolari A, Pignone A, Generini S, Matucci Cerinic M (1999) Reduction of bcl-2 expression in T cells during immunosuppressive therapy in patients with severe juvenile onset systemic lupus erythematosus. Clin Immunol 93:59–64
McDonald DM, Bowden JJ, Baluk P, Bunnet NW (1996) Neurogenic inflammation. A model for studying efferent actions of sensory nerves. Adv Exp Med Biol 410:453–462
Lu B, Figini M, Emanueli C, Geppetti P, Grady EF, Gerard NP, Ansell J, Payan DG, Gerard C, Bunnett N (1997) The control of microvascular permeability and blood pressure by neutral endopeptidase. Nat Med 3:904–907
Hwang L, Leichter R, Okamoto A, Payan D, Collins SM, Bunnet NW (1993) Down regulation of neutral endopeptidase (EC 3.4.24.11) in the inflamed rat intestine. Am J Physiol 264: G735–G743
Appleboom T, de Maertelear V, de Prez E, Hauzeur JP, Deschodt-Lanckman M (1991) Enkephalinase: a physiologic neuroimmunomodulator detected in the synovial fluid. Arthritis Rheum 34:1048–1051
Solan NJ, Ward PE, Sanders SP, Towns MC, Bathon JM (1998) Soluble recombinant neutral endopeptidase (CD10) as a potential anti-inflammatory agent. Inflammation 22:107–121
Figini M, Emanueli C, Grady EF, Kirkwood K, Payan DG, Ansel J, Gerard G, Geppetti P, Bunnet N (1997) Substance P and bradykinin stimulate plasma extravasation in the mouse gastrointestinal tract and pancreas. Am J Physiol 272:G785–G793
Sturiale S, Barbara G, Qiu B, Figini M, Geppetti P, Gerard N, Gerard C, Grady EF, Bunnet NW, Collins SM (1999) Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P. Proc Natl Acad Sci U S A 96:11653–11658
Tudoric N, Zhang M, Kljajic-Turkalj M, Niehus J, Cvoriscec B, Jurgovsky K, Kunkel G (2000) Allergen inhalation challenge induces decrease of serum neutral endopeptidase (NEP) in asthmatics. Peptides 21:359–364
Painter RG, Dukes R, Sullivan J, Carter R, Erdos EG, Johnson AR (1988) Function of neutral endopeptidase on the cell membrane of human neutrophils. J Biol Chem 263:9456–9461
Ziaber J, Baj Z, Pasnik J, Chmielewski H, Tchorzewski H (2000) Increased expression of neutral endopeptidase (NEP) and aminopeptidase N (APN) on peripheral blood mononuclear cells in patients with multiple sclerosis. Immunol Lett 71:127–129
Joshi DD, Dang A, Yadav P, Qian J, Bandari PS, Chen K, Donnelly R, Castro T, Gascon P, Haider A, Rameshwar P (2001) Negative feedback on the effects of stem cell factor on hematopoiesis is partly mediated through neutral endopeptidase activity on substance P: a combined functional and proteomic study. Blood 98:2697–2706
Borson DB (1991) Roles of neutral endopeptidase in airways. Am J Physiol 260: L212–L225
Haqqi TM, Anthony DD, Gupta S, Ahmad N, Lee MS, Kumar GK, Mukhtar H (1999) Prevention of collagen-induced arthritis in mice by polyphenolic fraction from green tea. Proc Natl Acad Sci U S A 96:4524–4529
Chevrier A, Mort SJ, Crine P, Hoemann CD, Buschmann MD (2001) Soluble recombinant neprilysin induces aggrecanase-mediated cleavage of aggrecan in cartilage explant cultures. Arch Biochem Biophys 15:178–186
Graf K, Kunkel G, Zhang M (1995) Activation of adenylate cyclase and phosphodiesterase inhibition enhance NEP activity in human endothelial cells. Peptides 16:1273–1278
Cohen AJ, Franklin WA, Magill C, Sorenson J, Miller YO (1999) Low neutral endopeptidase levels in bronchoalveolar lavage fluid of lung cancer patients. Am J Respir Cri Care Med 159:907–910
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Simonini, G., Azzari, C., Gelli, A.M.G. et al. Neprilysin levels in plasma and synovial fluid of juvenile idiopathic arthritis patients. Rheumatol Int 25, 336–340 (2005). https://doi.org/10.1007/s00296-004-0447-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-004-0447-z